Phenylketonuria Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You (or someone legally authorized to speak for you) must agree to take part before joining, following any rules required in your country
- You must currently be pregnant, or have recently been pregnant (including if the outcome of the pregnancy is not yet known, or if you have already had prenatal tests such as an ultrasound or amniocentesis)
- You must have been diagnosed with PKU (phenylketonuria) according to your local doctor's standard practice
- You must have been treated with a medication called pegvaliase at any point starting from 2 weeks before the first day of your last menstrual period
- You must agree to allow the study team to contact your doctors, midwife, or nurses — and your baby's doctors — to collect medical information
Who may not be able to join:
- You cannot currently be taking part in another clinical study sponsored by BioMarin that involves an investigational (experimental) medicine, device, or procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, MD, BioMarin Pharmaceutical
Phone: 1-800-983-4587
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pregnancy outcome and infant development for women who have been treated with Palynziq (pegvaliase) within 2 weeks of their last menstrual period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.